CellectGen’s core mission is to improve screening and treatment outcomes by providing clinicians the right information, in the right place, at the right time.
| Website | http://www.cellectgen.com |
| Revenue | $3 million |
| Employees | 4 (2 on RocketReach) |
| Founded | 2018 |
| Address | 2265 E Foothill Blvd, Pasadena, California 91107, US |
| Phone | +1 818-839-0414 |
| Technologies | |
| Industry | Biotechnology Research, Manufacturing General, Manufacturing |
| Keywords | Cancer Diagnostics, Oncology, Diagnostic Testing, Precision Medicine, Clinical Diagnostics, Disease Diagnostics, Cell Separation, Liquid Biopsy, Molecular Diagnostics, Immunology, Therapeutic Solutions, Biotechnology, Hematology, Drug Development, Clinical Trials, Life Sciences, Healthcare Technology, Medical Devices, Patient Care |
| Competitors | Roche, Thermo Fisher Scientific, Agilent Technologies, Illumina, PerkinElmer, Inc., Bio-Rad Laboratories, Promega Corporation, GenomeDx Biosciences Inc., Sengenics, BD Biosciences +35 more (view full list) |
| SIC | SIC Code 384 Companies, SIC Code 38 Companies |
| NAICS | NAICS Code 339 Companies, NAICS Code 33 Companies |
Looking for a particular CellectGen, Inc. employee's phone or email?
The CellectGen, Inc. annual revenue was $3 million in 2026.
Adam Markaryan is the Chief Research Officer of CellectGen, Inc..
2 people are employed at CellectGen, Inc..
CellectGen, Inc. is based in Pasadena, California.
The NAICS codes for CellectGen, Inc. are [339, 33].
The SIC codes for CellectGen, Inc. are [384, 38].